Dong Moon Shin, MD, FACP
Dong Moon Shin, MD, FACP
Frances Kelly Blomeyer Distinguished Chair in Cancer Research, Professor of Hematology and Medical
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner, PM Harari, J Giralt, N Azarnia, DM Shin, RB Cohen, CU Jones, ...
New England Journal of Medicine 354 (6), 567-578, 2006
Nanoparticle Therapeutics: An Emerging New Treatment Modality for Cancer
ME Davis, Z Chen, DM Shin
Nature Reviews Drug Discovery 7, 771-782, 2008
Therapeutic nanoparticles for drug delivery in cancer
K Cho, XU Wang, S Nie, Z Chen, DM Shin
Clinical cancer research 14 (5), 1310-1316, 2008
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
X Qian, XH Peng, DO Ansari, Q Yin-Goen, GZ Chen, DM Shin, L Yang, ...
Nature biotechnology 26 (1), 83-90, 2008
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ...
New England Journal of Medicine 357 (17), 1705-1715, 2007
Recent advances in head and neck cancer
RI Haddad, DM Shin
New England Journal of Medicine 359 (11), 1143-1154, 2008
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
R Sinha, GJ Kim, S Nie, DM Shin
Molecular cancer therapeutics 5 (8), 1909-1917, 2006
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
JA Roth, D Nguyen, DD Lawrence, BL Kemp, CH Carrasco, DZ Ferson, ...
Nature medicine 2 (9), 985-991, 1996
Induction of p53 regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy
SG Swisher, JA Roth, R Komaki, J Gu, JJ Lee, M Hicks, J Ro, WK Hong, ...
Clin Cancer Res 9, 93-101, 2002
Application of nanotechnology in cancer therapy and imaging
X Wang, L Yang, Z Chen, DM Shin
CA: a cancer journal for clinicians 58 (2), 97-110, 2008
Perspectives for cancer prevention with natural compounds
ARMR Amin, O Kucuk, FR Khuri, DM Shin
Journal of clinical oncology 27 (16), 2712, 2009
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors: a new paradigm for cancer therapy
RS Herbst, DM Shin
Cancer 94 (5), 1593-1611, 2002
Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy
XH Peng, X Qian, H Mao, AY Wang, C Z(G), SM Nie, DM Shin
Int J Nanomedicine 3 3, 311-321, 2008
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
WK Murphy, FV Fossella, RJ Winn, DM Shin, HE Hynes, HM Gross, ...
JNCI: Journal of the National Cancer Institute 85 (5), 384-388, 1993
Predicting cancer development in oral leukoplakia: ten years of translational research
JJ Lee, WK Hong, WN Hittelman, L Mao, R Lotan, DM Shin, SE Benner, ...
Clinical Cancer Research 6 (5), 1702-1710, 2000
Cancer prevention with natural compounds
NP Gullett, ARMR Amin, S Bayraktar, JM Pezzuto, DM Shin, FR Khuri, ...
Seminars in oncology 37 (3), 258-281, 2010
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck
RS Herbst, M Arquette, DM Shin, K Dicke, EE Vokes, N Azarnia, WK Hong, ...
Journal of Clinical Oncology 23 (24), 5578-5587, 2005
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands
X Huang, X Peng, Y Wang, Y Wang, DM Shin, MA El-Sayed, S Nie
ACS nano 4 (10), 5887-5896, 2010
Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis
DM Shin, JY Ro, WK Hong, WN Hittelman
Cancer research 54 (12), 3153-3159, 1994
The system can't perform the operation now. Try again later.
Articles 1–20